Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas

Histopathology

Volumn 56, Issue 5, 2010, Pages 600-606

  Riener, Marc Oliver ^a,b   Fritzsche, Florian R ^a   Soll, Christopher ^c   Pestalozzi, Bernhard C ^a   Probst Hensch, Nicole ^a   Clavien, Pierre Alain ^c   Jochum, Wolfram ^d   Soltermann, Alex ^a   Moch, Holger ^a   Kristiansen, Glen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Department of Surgery   (Switzerland)

^d Institute of Pathology   (Switzerland)

Author keywords

Bile duct carcinoma; EMT; Hepatocellular carcinoma; Periostin; Prognosis

Indexed keywords

TRANSCRIPTION FACTOR RUNX2; TUMOR MARKER;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FEMALE; GENE OVEREXPRESSION; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; FEMALE; FOCAL NODULAR HYPERPLASIA; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; SWITZERLAND; TISSUE ARRAY ANALYSIS; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 77950497099     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03527.x     Document Type: Article

References (26)

1. Hamilton DW. Functional role of periostin in development and wound repair: implications for connective tissue disease. J. Cell. Commun. Signal. 2008 2 9 17.
2. Yan W, Shao R. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J. Biol. Chem. 2006 281 19700 19708.
3. Baril P, Gangeswaran R, Mahon PC et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene 2007 26 2082 2094.
4. Erkan M, Kleeff J, Gorbachevski A et al. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 2007 132 1447 1464.
5. Bao S, Ouyang G, Bai X et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 2004 5 329 339.
6. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002 62 5358 5364.
7. Siriwardena BS, Kudo Y, Ogawa I et al. Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br. J. Cancer 2006 95 1396 1403.
8. Gonzalez HE, Gujrati M, Frederick M et al. Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 2003 129 754 759.
9. Sasaki H, Dai M, Auclair D et al. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer 2001 92 843 848.
10. Kim CJ, Yoshioka N, Tambe Y, Kushima R, Okada Y, Inoue H. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. Int. J. Cancer 2005 117 51 58.
11. Yoshioka N, Fuji S, Shimakage M et al. Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 gene. Exp. Cell Res. 2002 279 91 99.
12. Sasaki H, Yu CY, Dai M et al. Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res. Treat. 2003 77 245 252.
13. Soltermann A, Tischler V, Arbogast S et al. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin. Cancer Res. 2008 14 7430 7437.
14. Kanno A, Satoh K, Masamune A et al. Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells. Int. J. Cancer 2008 122 2707 2718.
15. Tilman G, Mattiussi M, Brasseur F, van BarenN, Decottignies A. Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol. Cancer 2007 6 80.
16. Riener MO, Wild PJ, Soll C et al. Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma. Int. J. Cancer 2009 124 352 357.
17. Riener MO, Stenner F, Liewen H et al. Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology 2009 49 1602 1609.
18. Riener MO, Bawohl M, Clavien PA, Jochum W Rare PIK3CA hotspot mutations in carcinomas of the biliary tract. Genes Chromosomes Cancer 2008 47 363 367.
19. Takeshita S, Kikuno R, Tezuka K, Amann E Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J. 1993 294 (Pt 1 271 278.
20. Horiuchi K, Amizuka N, Takeshita S et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res. 1999 14 1239 1249.
21. Fukushima N, Kikuchi Y, Nishiyama T, Kudo A, Fukayama M. Periostin deposition in the stroma of invasive and intraductal neoplasms of the pancreas. Mod. Pathol. 2008 21 1044 1053.
22. Kikuchi Y, Kashima TG, Nishiyama T et al. Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon. J. Histochem. Cytochem. 2008 56 753 764.
23. Kim CJ, Isono T, Tambe Y et al. Role of alternative splicing of periostin in human bladder carcinogenesis. Int. J. Oncol. 2008 32 161 169.
24. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J. Biol. Chem. 2007 282 22089 22101.
25. Lahsnig C, Mikula M, Petz M et al. ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Oncogene 2009 28 638 650.
26. Battaglia S, Benzoubir N, Nobilet S et al. Liver cancer-derived hepatitis C virus core proteins shift TGF-Beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS ONE 2009 4 e4355.